• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792

Introduction to (1S,3R)-3-aminocyclopentanol;hydrochloride (CAS No. 1259436-59-3)

Chemical compound (1S,3R)-3-aminocyclopentanol;hydrochloride, identified by the CAS number 1259436-59-3, is a significant molecule in the field of pharmaceutical research and development. This compound has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The stereochemistry of the molecule, specifically the (1S,3R) configuration, plays a crucial role in its biological activity and interaction with target enzymes or receptors.

The hydrochloride salt form of (1S,3R)-3-aminocyclopentanol enhances its solubility in aqueous solutions, making it more suitable for various pharmacological studies and formulations. This property is particularly valuable in drug design, where bioavailability and solubility are critical factors determining the efficacy of a therapeutic agent.

Recent advancements in the field of drug discovery have highlighted the importance of chiral compounds in developing selective and potent pharmaceuticals. The enantiomeric purity of (1S,3R)-3-aminocyclopentanol;hydrochloride is essential for ensuring optimal pharmacokinetic and pharmacodynamic profiles. Researchers have employed sophisticated techniques such as chiral chromatography and X-ray crystallography to confirm the stereochemical integrity of this compound.

In vitro studies have demonstrated that (1S,3R)-3-aminocyclopentanol;hydrochloride exhibits promising interactions with various biological targets. For instance, its ability to modulate enzyme activity has been explored in the context of developing novel treatments for neurological disorders. The amine group in the cyclopentane ring provides a versatile scaffold for further chemical modifications, enabling the synthesis of derivatives with enhanced biological activity.

The hydrochloride form of this compound has been utilized in preclinical trials to evaluate its potential as a therapeutic agent. Preliminary results suggest that it may have therapeutic benefits in conditions characterized by abnormal enzyme function or receptor signaling. These findings have spurred further investigation into the mechanisms by which (1S,3R)-3-aminocyclopentanol;hydrochloride exerts its effects at the molecular level.

The synthesis of (1S,3R)-3-aminocyclopentanol;hydrochloride involves multi-step organic reactions that require precise control over reaction conditions to achieve high yield and enantiomeric purity. Advances in synthetic methodologies, such as asymmetric catalysis and biocatalysis, have facilitated the efficient production of this compound on a laboratory scale. These innovations are crucial for enabling large-scale pharmaceutical manufacturing and ensuring consistent quality control.

Future research directions for (1S,3R)-3-aminocyclopentanol;hydrochloride include exploring its potential applications in combination therapies and investigating its long-term safety profile. Collaborative efforts between academic institutions and pharmaceutical companies are essential for translating laboratory findings into clinical applications that benefit patients worldwide. The continued study of this compound represents a significant contribution to the advancement of medicinal chemistry and drug development.

The growing interest in stereoselective pharmacology underscores the importance of compounds like (1S,3R)-3-aminocyclopentanol;hydrochloride in addressing unmet medical needs. By leveraging cutting-edge technologies and interdisciplinary approaches, researchers aim to unlock the full therapeutic potential of this molecule. The journey from initial discovery to clinical use is a testament to the dedication and expertise of scientists who strive to improve human health through innovative chemical solutions.

• 124555-33-5(trans-3-Aminocyclopentanol hydrochloride)
• 946593-67-5((1S,3S)-3-Aminocyclopentanol)
• 1110772-05-8((1R,3S)-3-Aminocyclopentanol)
• 1279032-31-3((1R,3S)-3-aminocyclopentanol;hydrochloride)
• 124555-42-6(cis 3-aminocyclopentanol)
• 946826-74-0((1R,3R)-3-aminocyclopentanol)
• 1284248-73-2(cis-3-aminocyclopentanol hydrochloride)
• 13725-38-7(3-Aminocyclopentanol)
• 167298-58-0(trans-3-Aminocyclopentanol)
• 1036260-18-0((1S,3R)-3-aminocyclopentanol)